← All trials
NCT01377285
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2010
- Primary completion
- Dec 1, 2018
- Completion date
- Dec 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 350
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- National Taiwan UniversityLead sponsor
- National Taiwan UniversityOverall official - principal investigator
- Far Eastern Memorial HospitalCollaborator
- Shin Kong Wu Ho-Su Memorial HospitalCollaborator
- Cathay General HospitalCollaborator
- Mackay Medical CollegeCollaborator
- Taipei Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.